phase readout
saveNCT04958265: A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Atypical Hemolytic Uremic Syndrome
view source ↗
comments(0)
5-min edit window · permanent after that